bortezomib will increase the degree or result of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Increased flibanserin adverse effects could come about if coadministered with various weak CYP3A4 inhibitors. B: Could be acceptable. Possibly animal reports d